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A B S T R A C T
Primary cardiac tumors are rare lesions in childhood, with the two most common being rhabdomyoma and fibroma.
We report two infants who successfully underwent orthotopic heart transplant for massive interventricular septal
cardiac fibromas. For unresectable infantile cardiac fibroma, orthotopic heart transplant may be considered a
therapeutic option.
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Introduction
Fibroma is the second most common cardiactumor after rhabdomyoma in children.1
Cardiac fibroma is usually a large, solitary, firm,
nonencapsulated tumor that arises from the left
ventricular free wall or septum and tends not to
regress spontaneously.1 Complete surgical resec-
tion has been reported with an excellent outcome.2
In certain cases, however, the tumor may be unre-
sectable because of potential risk to vital cardiac
structures.3 We report two infants who success-
fully underwent orthotopic heart transplantation




A fetal echocardiogram obtained in a 44-year-old
G11P6 mother at 30 weeks gestation revealed a
large solitary mass occupying most of the fetal
left ventricle. There was no obstruction to left
ventricular inflow or outflow. A repeat fetal
echocardiogram at 31 weeks gestation revealed an
enlarging mass with no signs of congestive heart
failure (Figure 1A). The infant was born at 33
weeks gestation via emergent Cesarean section
because of chorioamnionitis, with a birth weight
of 2135 g. The Apgar scores were six and eight at
1 and 5 minutes, respectively. At birth, she was
asymptomatic and had no dysmorphic features.
The postnatal echocardiogram confirmed a soli-
tary mass arising from the interventricular septum
and occupying most of the left ventricular cavity
without restriction to flow (Figure 1B). Mild to
moderate mitral insufficiency was noted without
pericardial effusion. A cardiac magnetic resonance
imaging (MRI) confirmed that the mass arising
from the interventricular septum measured 4.0 ¥
2.0 cm and occupied most of the left ventricular
cavity (Figure 2). Brain MRI and abdominal ultra-
sound were unremarkable. She remained asymp-
tomatic until 2 months of age, when her enlarging
tumor caused respiratory distress that is character-
ized by tachypnea and mild retractions. Repeat
echocardiography showed an interval increase in
tumor size with increased internal heterogeneity
(Figure 1C). Repeat MRI revealed that the mass
measuring 4.8 ¥ 4.5 ¥ 4.0 cm was homogeneously
isointense on T1 sequences and hypointense on
gradient-echo sequences (Figure 2). There was
heterogeneous peripheral contrast enhance-
ment with areas of central nodular enhancement
within the mass lesion. Cardiac catheterization
was performed to assess hemodynamics. During
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catheterization, the tumor was thought to be
approachable by biopsy catheter, and as the possi-
bility of malignancy was not entirely excluded in
the rapidly growing tumor, a diagnostic endomyo-
cardial biopsy was performed. Systolic right ven-
tricular pressure was two-thirds of systemic with a
peak gradient of 20 mm Hg across the right ven-
tricular outflow tract. The mean left atrial pressure
was 7 mm Hg with a-wave of 11 mm Hg. The
end-diastolic left ventricular pressure was
4 mm Hg. The pulmonary vascular resistance was
2.3 indexed Woods unit. This slight increase in the
pulmonary vascular resistance was not a contrain-
dication for OHT. There was no gradient across
the left ventricular outflow tract. Endomyocardial
biopsy was not diagnostic. An open biopsy was
obtained at 4 months of age, which suggested
cardiac fibroma. Following the biopsy, the infant
had difficulty weaning off the ventilator; broncho-
scopy revealed compression of the left bronchus.
The tumor was deemed to be unresectable, there-
fore the infant was listed for OHT and received an
organ after 3 months. She remained intubated for
the entire period. Macroscopic examination of the
explanted heart revealed a well-circumscribed
mass measuring 6.8 ¥ 4.8 ¥ 4.6 cm located within
the interventricular septum and posterior wall
(Figure 3). The cut surface of the mass was firm
pink–tan with fine trabeculation. Microscopic
examination confirmed a cardiac fibroma that is
characterized by fibroblasts admixed with scat-
tered collagen bundles. Cytogenetic testing of
fibroblasts revealed 46XX, del(9)(q21.2q34) in all
the 20 cultured metaphase cells. Following her
OHT, she required prolonged intubation but was
eventually extubated after 36 days and was dis-
Figure 1. Case 1. (A) Four-chamber view on fetal echocardiography at 31 weeks gestation, showing the large interven-
tricular mass occupying the left ventricle. (B) Four-chamber view at 1 day of age, showing a solitary mass arising from the
interventricular septum. (C) Four-chamber view at 2 month of age, showing increased internal heterogenicity.
Figure 2. Case 1. Cardiac MRI. (A) Four-chamber view, showing that the mass was homogeneously isointense on T1
sequences. (B) Four-chamber view with contrast, showing heterogeneous peripheral enhancement with areas of central
nodular enhancement within the lesion. (C) Coronal view with contrast.
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charged after 46 days. At the latest follow-up after
3 years, she remains asymptomatic and has had no
return of any intracardiac mass or other tumors.
Case 2
This infant was born to a 27-year-old G3P2
mother at 40 weeks gestation via Cesarean section.
Prenatal history was unremarkable. She required
bag and mask ventilation at delivery. The Apgar
scores were two and nine at 1 and 5 minutes,
respectively. She was large for gestational age, with
a birth weight of 3991 g. A chest x-ray performed
for respiratory distress revealed cardiomegaly.
Karyotype was 46XX. Echocardiogram showed a
large mass in the interventricular septum occupy-
ing much of the left ventricular cavity and imping-
ing on the left ventricular outflow tract (Figure 4).
A moderate pericardial effusion was treated with
pericardiocentesis. Cytology of pericardial fluid
showed numerous neutrophils and monocytes
without malignant cells. Cardiac MRI confirmed
that the mass arose from the interventricular
septum, occupied the superior left ventricle, and
measured 4.7 ¥ 4.5 ¥ 2.6 cm (Figure 5). The mass
was homogeneously isointense on T1 sequences
and mildly hyperintense on T2 sequences. There
was irregular peripheral contrast enhancement
that extended into the free wall of the left
ventricle, suggesting that the tumor was invading
the left ventricular wall. Brain and abdominal
MRI were unremarkable. The tumor appeared
unresectable because of its size, location, and
permeation of the septum, therefore, she was
listed for OHT. She was discharged home at 3
weeks of age, with nasogastric tube feeding for
poor weight gain. Over the next 6 months, she
required several hospitalizations because of respi-
ratory distress and failure to thrive. Serial echocar-
diography showed a persistent large cardiac tumor.
At 4 months of age, she developed severe respira-
tory distress and required emergent intubation
because of complete collapse of the left mainstem
bronchus on bronchoscopy. She required inotro-
pic support for impaired cardiac function. A
successful OHT was performed at 6 months of
age. Macroscopic examination showed a large
Figure 3. Case 1. (A) Macroscopic examination of the explanted heart, showing a well-circumscribed mass measuring 6.8
¥ 4.8 ¥ 4.6 cm located within the interventricular septum and posterior wall. (B) The cut surface of the mass was firm pink–tan
with fine trabeculation.
Figure 4. Case 2. Echocardiography at 1 day of age. (A) Short-axis view, showing a large mass occupying most of the left
ventricle as well as a moderate pericardial effusion. (B) Long-axis view, showing a mass arising from the interventricular
septum. (C) Four-chamber view, showing the interventricular mass, occupying both of the ventricles.
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solid gray–white tumor measuring 6 ¥ 4 ¥ 7 cm,
which arose from the interventricular septum and
compressed the cardiac conducting bundles
(Figure 6). The tumor occupied the entire cavity
of both ventricles. There was a focal small cleft-
like cystic area measuring 0.6 cm in diameter.
Microscopic examination confirmed a cardiac
fibroma. Cytogenetic testing of fibroblasts was
unsuccessful. Following her OHT, she was suc-
cessfully extubated after 22 days and was dis-
charged after 34 days. She remains asymptomatic
at her 19 months of follow-up and has had no
recurrence or other tumors.
Discussion
Primary cardiac tumors are rare lesions with a
reported incidence of <0.1%.1 Among the pediat-
ric cardiac tumor, rhabdomyoma is the most
common; fibroma is the second most common
with more than 80% of cardiac fibromas occurring
in children.4 Cardiac fibroma often involves the
left ventricular free wall or septum and less fre-
quently involves the right ventricle and atria.1
Microscopic features include the presence of
fibroblasts with no encapsulation with infiltration
of the tumor at the junctional areas between the
tumor and the normal tissues.4 Focal calcification
is frequent with occasional cystic degeneration.1
Although cardiac fibromas are considered histo-
logically benign, they can manifest as arrhyth-
mias5,6 and sudden death7 and lead to congestive
heart failure secondary to hemodynamic obstruc-
tion. In our two cases, the cardiac fibroma caused
bronchial compression and respiratory distress
requiring intubation.
Figure 5. Case 2. Cardiac MRI. (A) Four-chamber view, showing that the mass was homogeneously isointense on T1
sequences. (B) Four-chamber view with contrast, showing heterogeneous peripheral enhancement. (C) Axial view with
contrast.
Figure 6. Case 2. (A) Macroscopic examination of the explanted heart, showing a well-circumscribed mass measuring 6 ¥
4 ¥ 7 cm located within the interventricular septum. (B) The cut surface of the mass was firm gray–white, with a focal small
cleft-like cystic area measuring 0.6 cm in diameter.
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Symptomatic fibromas have been successfully
treated with partial or complete resection.2,8 When
complete resection is not possible, partial resection
or “debulking” can help to restore normal hemo-
dynamic and respiratory function.9,10 A palliative
approach has been recently reported in infants with
hemodynamic obstruction because of cardiac
fibroma.11,12 An infant with a large right ventricular
fibroma underwent a Blalock–Taussing shunt as
initial palliation and subsequently completed resec-
tion of the tumor at 9 years of age.11 Freire et al.
reported that two neonates with large left ventricu-
lar fibroma underwent the hybrid procedure (bilat-
eral pulmonary artery banding, ductal stenting,
followed by balloon atrial septostomy), resulting in
univenricular physiology.12 In our two cases, the
tumors were deemed to be unresectable because of
their location, aggressive growth, difficulty in dis-
tinguishing them from myocardium, and risk to
conduction pathways. In addition, debulking and
other palliative options were considered but were
thought to be unlikely to relieve bronchial com-
pression and posed risks of continued growth and
arrhythmias. Therefore, OHT was selected as
definitive therapy. OHT has been performed in
unresectable primary cardiac tumors.3 Scattered
case reports have previously described successful
OHT in infants with cardiac fibroma.13–15
An echocardiogram remains the initial diagnos-
tic noninvasive modality to evaluate cardiac func-
tion and hemodynamic disturbance secondary to
tumor. Cardiac MRI is an excellent imaging
modality to delineate the extent and size of the
cardiac tumor and to detect compression on con-
tiguous extracardiac structures. Cardiac fibroma
appears as a low signal on T1-weighted images
and homogeneously hypointense or low signal on
T2-weighted sequences while being relatively
hypovascular on first-pass perfusion imaging and
homogeneous, peripheral, or heterogeneous on
delayed enhancement.16 Rhabdomyomas, on the
other hand, are isointense to marginally hyperin-
tense to myocardium on T1-weighted images and
hyperintense on T2-weighted images while being
hypointense to myocardium after contrast admin-
istration.17 Gadolinium contrast administration
is useful for tissue characterization and im-
proves mass delineation. Heterogeneous delayed
enhancement suggests regional variations in vas-
cularity and distribution volumes such as seen with
areas of necrosis within a tumor. Hoffmann et al.
reported on the usefulness of cardiac MRI to dis-
tinguish malignant from benign cardiac and para-
cardiac masses in 55 patients.18 The predictors for
malignant cardiac or paracardiac masses were
right-sided cardiac location, inhomogeneity of
tumor tissue, and presence of effusion. Pediatric
data on the utility of MRI in tumors are scarce.
Kiaffas et al. described cardiac MRI characteristics
in 11 infants and children with primary cardiac
tumors.19 It has been suggested that cardiac MRI
is useful in children with cardiac tumors in whom
the diagnosis of rhabdomyoma is considered un-
likely because rhabdomyoma is usually easily
diagnosed by echocardiography. A T2-weighted
spin echo sequence helps to distinguish vascular
tumors, such as hemangiomas from avascular
tumors such as fibroma. Although there is no
pathognomic finding in cardiac MRI, it can
provide important diagnostic information about
tumor tissue characteristics, anatomy, and hemo-
dynamic consequences.
Cardiac fibroma occurs sporadically or as a
feature of Gorlin syndrome, a rare autosomal
dominant disorder characterized by basal cell car-
cinoma, craniofacial, central nervous system, mus-
culoskeletal, and genitourinary abnormalities.20
Gorlin syndrome is caused by mutations in the
PTCH1 that is located in 9q22.3 and acts as a
tumor suppressor gene.20 Scanlan et al. recently
reported homozygous or heterozygous loss of the
PTCH1 locus that was identified in three non-
syndromic cardiac fibromas.21 There are two
other cardiac fibromas reporting genetic rear-
rangements of 9q22 at (1;9)(q32)22 and at
(1;9;5)(q24’q22;q22).23 In our case 1, cytogenetic
testing of fibroblasts revealed abnormal
metaphases having a partial/interstitial deletion in
the deletion of chromosome 9q21.2q34 as a clonal
abnormality.
In summary, we report two infants with unresec-
table interventricular septal cardiac fibroma who
successfully underwent OHT in a contemporary
era when OHT outcomes are much improved. A
large cardiac fibroma can cause bronchial compres-
sion, requiring mechanical ventilation. In case sur-
gical resection is not feasible, OHT may be
considered as an option of treatment.
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